Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare ... ( HAYWARD Calif. Jan. 4 2011 /- Intarci...)

Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference

Date:1/4/2011

HAYWARD, Calif., Jan. 4, 2011 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced that Kurt Graves, Executive Chairman of Intarcia Therapeutics, will present at the 29th Annual JP Morgan Healthcare Conference at 3:30 p.m. PST on Tuesday, January 11, 2011 at the Westin St. Francis Hotel in San Francisco, California.

(Logo: http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO)

About Intarcia

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to ensure enhanced treatment outcome by optimizing patient adherence and improving the efficacy, convenience and tolerability of drug therapies. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above body temperature and to deliver them in a constant and consistent manner via the proprietary DUROS® drug delivery platform. Intarcia is pursuing a clinical stage development program for type 2 diabetes and has other programs for weight regulation to control obesity.

About ITCA 650

ITCA 650 is an investigational therapy for the treatment of type 2 diabetes using Intarcia's proprietary drug delivery technology. In 2010, Intarcia completed Phase 2 development of ITCA 650 and is planning to initiate Phase 3 development in 2011. ITCA 650 delivers exenatide therapy from a matchstick-sized, miniature osmotic pump placed subcutaneously. ITCA 650 can deliver up to a full year of therapy from a single administration in a physician's office.

About Type 2 Diabetes

According to the National Institutes of Health (NIH), "Approximately 23.6 million Americans have type 2 diabetes, which represents 7.8 percent of the U.S. population and about 1/4 of them don't even know it. In addition, we now know that at least another 57 million Americans have 'pre-diabetes.'" Diabetes is conservat
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
2. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
3. Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel

Post Your Comments:

(Date:5/17/2013)... Research explores data on ... also to be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...

(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...

(Date:5/17/2013)... , May 17, 2013 Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...

[0] Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting [0] Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment [0] Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference

... As part of a three-year global initiative to identify ... problems around the world, Boehringer Ingelheim and Ashoka,s Changemakers® ... Health: Achieving Individual, Family, and Community Well-Being ... the most innovative models and solutions that are transforming ...

... Ascension Orthopedics, Inc., a world leader in PyroCarbon orthopedic ... Glenoid. The Mini Glenoid is yet another addition to the ... way to address glenoid arthritis. "The Mini ... the glenoid as well as load-share with the peripheral glenoid ...

Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2 Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3 Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid 2

Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition Ascension Orthopedics Announces Market Release of TITAN™ Inset Mini Glenoid

(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...

(Date:5/19/2013)... The Da Vinci robot lawyers at Wright & ... first trial involving a Da Vinci surgical robot lawsuit. ... was filed by the widow of a man who ... robot-assisted prostate removal, according to a report from Bloomberg ... alleges those complication’s hastened his death. (Estate of ...

(Date:5/18/2013)... The American Society for Gastrointestinal Endoscopy (ASGE) will honor ... ninth annual ASGE Crystal Awards on Sunday, May 19, ... year,s event will begin at ... Held in conjunction with Digestive Disease Week (DDW), the ... and scientific pursuit. The event will recognize the 2013 ...

(Date:5/18/2013)... Online watch retailer Time and Gems is offering ... at a fraction of its usual cost. With great deals ... buyers are urged to take advantage of Time and Gems’ ... from a brick-and-mortar store, buyers now have the option of ... unbelievable rates. Although some buyers may have qualms about buying ...

(Date:5/18/2013)... (HealthDay News) -- Just a few extra cups of ... an autoimmune liver disease known as primary sclerosing cholangitis ... Mayo Clinic in Rochester, Minn., found that drinking coffee ... disease, which can lead to cirrhosis of the liver, ... not prove a cause-and-effect relationship. "While rare, ...

Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2 Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2 Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3 Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4 Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2 Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3 Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4 Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5 Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6 Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7 Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2 Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3 Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2

[0] Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent [0] Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial [0] ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando [0] Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet [0] Study Links Coffee to Lower Risk for Rare Liver Disease

... with BMI of 35 or more 10.5 times more ... (HealthDay News) -- Obese patients are at increased risk ... surgery, according to a study by researchers at Geneva ... of obesity on the incidence of serious complications after ...

... 23 Rising Medical Solutions, Inc.,(Rising), a leading ... ranked number one amongst its peers on the ... for Q1 2008., (Photo: http://www.newscom.com/cgi-bin/prnh/20080523/AQF004LOGO ), ... is generated each quarter,by PCI analysts who review ...

... Memorial University,Medical Center (MUMC) now offers a ... incision in the belly button. It,s called single,incision ... nationwide,are skilled in the SILS technique. One of ... Senkowski can remove the gallbladder through a,1cm. incision ...

... Sessions This Week, DELRAY BEACH, Fla., May 23 ... former Division One college soccer coaches have,joined the club,s ... kick off this week., "We,re pleased to welcome ... coaches of Division One college soccer teams, to our ...

... of gas found in car exhaust provides anti-inflammatory effects ... Low doses of carbon monoxide (CO) -- the potentially ... protect the lungs of patients undergoing cardiopulmonary bypass (CPB) ... doses of CO to pigs that underwent beating-heart CPB. ...

... China, May 23 /Xinhua-Prnewswire-FirstCall/ -- China Sky One,Medical, ... and,distributor of pharmaceutical, medicinal and diagnostic products in ... approved for listing on,the American Stock Exchange (AMEX). ... the symbol "CSY". This approval is contingent upon ...

Cached Medicine News:Health News:Obese Patients at Greater Infection Risk After Hip Replacement 2 Health News:Rising Garners Top Honors on the Private Company Index's 'Top Five Growth Companies' List for Q1 2008 2 Health News:SILS Surgical Technique Now Available at MUMC 2 Health News:Delray Beach Soccer Club Signs Division One College Soccer Coaches 2 Health News:Carbon Monoxide May Help Bypass Surgery Patients 2 Health News:China Sky One Medical, Inc. Approved for Listing on the American Stock Exchange 2

Obese Patients at Greater Infection Risk After Hip Replacement Rising Garners Top Honors on the Private Company Index's 'Top Five Growth Companies' List for Q1 2008 SILS Surgical Technique Now Available at MUMC Delray Beach Soccer Club Signs Division One College Soccer Coaches Carbon Monoxide May Help Bypass Surgery Patients China Sky One Medical, Inc. Approved for Listing on the American Stock Exchange

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Cystic Fibrosis 3199del6 Only(ARUP Medical Director or Genetic Counselor approval required prior to testing)Cyclosporine A Cyclic Citrullinated Peptide Antibody, IgG Cutaneous Direct Immunofluorescence, Biopsy